CEO Michael Petras Files to Sell $21.6M in Sotera Health Shares
SHC sits 44% above its 52-week low of $13.09 on elevated volume (2.7× avg).
Summary
CEO Michael Petras plans to sell $21.6M in Sotera Health stock, including 850,000 shares from a GRAT, marking his first sale in the 90-day window.
Key Events · Ownership and Investor Activity · SHC
-
CEO Files to Sell $21.6M
Michael B. Petras, Jr., Chairman and CEO, filed a Form 144 to sell 1,144,515 shares worth approximately $21.6 million.
-
GRAT Trust Included
850,000 of the shares are held by a May 2025 Grantor Retained Annuity Trust with Petras as trustee; the remaining 294,515 shares are held directly.
-
First Sale in 90 Days
This is Petras's first insider sale in the 90-day window, following strong Q2 2026 results and raised guidance on August 6.
-
Sale Date Set for Today
The approximate sale date is August 17, 2026, the same day as the filing.
Analysis · SHC · Industrial Applications And Services
A significant insider transaction has just been disclosed at Sotera Health. Chairman and CEO Michael B. Petras, Jr. filed a Form 144 to sell 1,144,515 shares worth approximately $21.6 million. The sale includes 850,000 shares held by a Grantor Retained Annuity Trust (GRAT) with Petras as trustee, and 294,515 shares held directly. This is the first insider sale by Petras in the 90-day window, and it comes just days after strong Q2 2026 results and raised guidance. While the sale is a routine diversification move for a CEO, the size relative to his holdings and the timing after a stock run-up make it a notable signal for investors.
At the time of this filing, SHC was trading at $18.80 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.4B. The 52-week trading range was $13.09 to $19.85. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.